Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
DSM Exits Citric Acid, Links With DuPont
by Marc S. Reisch
October 4, 2010
| A version of this story appeared in
Volume 88, Issue 40
DSM will sell Citrique Belge, its Belgium-based citric acid subsidiary, to privately held Adcuram for an undisclosed price. Citrique Belge, with 250 employees, had sales in 2009 of more than $135 million and a loss of more than $50 million. DSM decided in 2007 that citric acid did not fit its long-term plans. Separately, DSM has formed a joint venture, to be called Actamax Surgical Materials, with DuPont. The partners will develop surgical sealants and tissue adhesives based on DuPont hydrogel technology and DSM medical polymer manufacturing capabilities.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter